Clinical Trials · NCT00498901
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of Washington
- Enrollment
- 1
- Start date
- Feb 2007
- Locations
- 2 sites, United States
- Primary endpoint
- Overall response rate as measured by RECIST